In order to achieve first-class launch excellence, your teams need the right mindset and the right tools. In 2020, Board of Innovation teamed up with AstraZeneca to help the company do just that.
Through an intensive four-week program, we provided this leading biopharmaceutical company with crucial insights, valuable best practices, and a toolkit to elevate the impact of their future product launches.
Challenge
Addressing market changes and ecosystem expectations
Patient centricity and a focus on meeting the jobs-to-be-done of patients, HCPs and payers have profoundly changed the face of the pharmaceutical industry.
The rigid, scaling-focused multi-year plans that once served as models for launch excellence are now a thing of the past. Today, it’s all about navigating ever-accelerating market changes and meeting the expectations of the market ecosystem efficiently and with the right focus.
Solution
Cross-division co-creation
This is where Board of Innovation stepped in. We developed a four-week co-creation program with in-house AstraZeneca reps from all therapeutic areas and functions: commercial, medical, market access, etc.
Through critical three-hour sessions – strategic sprints, as we like to call them – we explored practical, simple and impactful tools and practices aimed at increasing launch impact.
More info about our Launch excellence programs?
Impact
Boosting product launch success
The program culminated in a toolkit that advanced the agile mindset of launch teams, providing an action-oriented framework to strengthen their current planning activities.
Among other things, we developed a tool to improve launch success with a set of tactics and strategies. These are fit both for cross-functional generative sessions and for developing specific solutions to particular challenges.
